Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alefacept for Resistant Chronic GVHD
NCT00397332Phase 2Completed
- Sponsor
- Hadassah Medical Organization
- Start
- Oct 2006
- Primary completion
- Jan 2013
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of alefacept in chronic graft-versus-host disease (cGVHD), sponsored by Hadassah Medical Organization. Started Oct 2006; status: completed.
02
Drugs
alefacept
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT00397332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00397332.